Patient Access & Affordability
  • About
    • Mission
    • Team
    • Advisors
    • Patient Advisors
    • Funding
    • Contact
  • Resources
    • Blog
    • Watch & Listen
    • Surveys
  • Publications
    • Research Briefings
    • Current Issues
    • Fast Facts
  • ICERWATCH
    • What is ICER?
    • ICER Glossary
    • Analysis and Commentary
    • Public Comments
Select Page
OPINION: Patients Should Fear Partnership Between the FDA and Anti-Research “Watchdog”

OPINION: Patients Should Fear Partnership Between the FDA and Anti-Research “Watchdog”

Mar 30, 2020

FDA regulators have approved more than 600 new medicines since the turn of the century. And more treatments are on the way. Scientists are currently developing more than 7,000 experimental drugs. Original article at NewtonDailyNews.com

Categories

  • Blog
  • Comments
  • ICERWatch
  • News
  • Opinion
  • QALY
  • Research
  • Resources
  • Video

IPAA

700 12th St. NW, Suite 700
Washington, DC 20005
202-750-1186 |  info@accessandaffordability.org

The Patient Access & Affordability Project is a program of Patients Rising, a national 501(c)3 nonprofit organization, and is governed by the Patients Rising Board of Directors.

  • Facebook
  • Twitter
  • RSS